Scarica l'app Stockscreener
5.53
5.15%
-0.30
Dopo l'orario di chiusura:
5.60
0.07
+1.27%
Precedente Chiudi:
$5.83
Aprire:
$5.82
Volume 24 ore:
1.55M
Relative Volume:
1.54
Capitalizzazione di mercato:
$331.22M
Reddito:
-
Utile/perdita netta:
$-44.80M
Rapporto P/E:
-7.3733
EPS:
-0.75
Flusso di cassa netto:
$-30.67M
1 W Prestazione:
-5.63%
1M Prestazione:
+8.86%
6M Prestazione:
-10.37%
1 anno Prestazione:
-12.50%
Intervallo 1D:
$5.50
$5.88
Intervallo di 1 settimana:
$5.50
$5.93
Portata 52W:
$1.14
$7.20
Aldeyra Therapeutics Inc Stock (ALDX) Company Profile
Nome
Aldeyra Therapeutics Inc
Settore
Industria
Telefono
781-761-4904
Indirizzo
131 HARTWELL AVENUE, LEXINGTON, MA
Confronta ALDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALDX
Aldeyra Therapeutics Inc
|
5.53 | 345.26M | 0 | -44.80M | -30.67M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-04-27 | Ripresa | H.C. Wainwright | Buy |
| 2021-02-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-16 | Iniziato | Berenberg | Buy |
| 2020-10-30 | Iniziato | Jefferies | Buy |
| 2020-10-16 | Iniziato | BTIG Research | Buy |
| 2020-09-22 | Iniziato | Alliance Global Partners | Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Outperform |
| 2018-12-04 | Iniziato | Citigroup | Buy |
| 2018-09-26 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Janney | Buy |
| 2018-01-26 | Iniziato | Seaport Global Securities | Buy |
| 2016-09-26 | Iniziato | H.C. Wainwright | Buy |
| 2016-07-01 | Iniziato | Stifel | Buy |
| 2015-07-01 | Iniziato | Canaccord Genuity | Buy |
| 2015-03-25 | Iniziato | Chardan Capital Markets | Buy |
| 2015-03-20 | Reiterato | H.C. Wainwright | Buy |
| 2014-11-18 | Iniziato | H.C. Wainwright | Buy |
| 2014-06-19 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie
Does Aldeyra Therapeutics Inc. have strong fundamentalsJuly 2025 Catalysts & Expert Curated Trade Setups - khodrobank.com
Can Aldeyra Therapeutics Inc. deliver consistent dividendsJuly 2025 Momentum & AI Based Buy and Sell Signals - khodrobank.com
News impact scoring models applied to Aldeyra Therapeutics Inc.2025 Institutional Moves & Growth Focused Investment Plans - Newser
Using economic indicators to assess Aldeyra Therapeutics Inc. potentialWeekly Trade Recap & Reliable Breakout Stock Forecasts - Newser
Can trapped investors hope for a rebound in Aldeyra Therapeutics Inc.Earnings Performance Report & Weekly High Return Stock Forecasts - Newser
Can Aldeyra Therapeutics Inc. generate free cash flowJuly 2025 Levels & Consistent Growth Stock Picks - khodrobank.com
Historical volatility pattern of Aldeyra Therapeutics Inc. visualized2025 Momentum Check & Risk Controlled Stock Pick Alerts - Newser
Using fundamentals and technicals on Aldeyra Therapeutics Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Is Aldeyra Therapeutics Inc. a candidate for recovery playQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser
Advanced analytics toolkit walkthrough for Aldeyra Therapeutics Inc.Weekly Gains Report & Daily Oversold Bounce Ideas - Newser
Sector ETF performance correlation with Aldeyra Therapeutics Inc.Portfolio Gains Report & Daily Technical Stock Forecast Reports - Newser
What technical models suggest about Aldeyra Therapeutics Inc.’s comeback2025 Short Interest & Reliable Price Action Trade Plans - Newser
Aldeyra Therapeutics: A High-Potential Biotech Play in Immune-Mediated and Ophthalmic Diseases - AInvest
Will Aldeyra Therapeutics Inc. outperform the marketMarket Rally & Weekly High Return Opportunities - Newser
Tech Rally: Is Aldeyra Therapeutics Inc. stock forming a cup and handleTrade Risk Summary & High Return Stock Watch Alerts - khodrobank.com
Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
Comparing Aldeyra Therapeutics Inc. in custom built stock radarsQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser
Real time scanner hits for Aldeyra Therapeutics Inc. explainedBreakout Watch & Daily Stock Trend Watchlist - Newser
Ranking Aldeyra Therapeutics Inc. among high performing stocks via tools2025 Price Momentum & Risk Managed Trade Strategies - Newser
Market reaction to Aldeyra Therapeutics Inc.’s recent newsMarket Performance Report & Daily Entry Point Alerts - Newser
Full technical analysis of Aldeyra Therapeutics Inc. stockJuly 2025 Summary & Safe Capital Preservation Plans - Newser
How to integrate Aldeyra Therapeutics Inc. into portfolio analysis toolsPortfolio Value Summary & Expert Verified Movement Alerts - Newser
Earnings visualization tools for Aldeyra Therapeutics Inc.Market Performance Report & Long-Term Capital Growth Ideas - Newser
What dividend growth rate does Aldeyra Therapeutics Inc. offer2025 Investor Takeaways & Technical Pattern Alert System - khodrobank.com
Is Aldeyra Therapeutics Inc. stock forming a cup and handle2025 Biggest Moves & Risk Managed Investment Strategies - khodrobank.com
Is Aldeyra Therapeutics Inc. trending in predictive chart modelsWeekly Trade Summary & Real-Time Sentiment Analysis - Newser
How moving averages guide Aldeyra Therapeutics Inc. trading2025 Market WrapUp & Risk Controlled Daily Plans - Newser
How to manage a losing position in Aldeyra Therapeutics Inc.Forecast Cut & Low Drawdown Momentum Trade Ideas - Newser
Backtesting results for Aldeyra Therapeutics Inc. trading strategiesIndex Update & Low Drawdown Trading Techniques - Newser
How to escape a deep drawdown in Aldeyra Therapeutics Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
Can machine learning forecast Aldeyra Therapeutics Inc. recoveryMarket Risk Analysis & Fast Moving Trade Plans - Newser
Is Aldeyra Therapeutics Inc. benefiting from interest rate changesJuly 2025 Snapshot & Verified Swing Trading Watchlist - khodrobank.com
Can Aldeyra Therapeutics Inc. expand its profit marginsWeekly Risk Report & Precise Entry and Exit Recommendations - خودرو بانک
Is Aldeyra Therapeutics Inc. stock bottoming outTrade Risk Assessment & Low Risk High Reward Ideas - Newser
Heatmap analysis for Aldeyra Therapeutics Inc. and competitorsStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Aldeyra Therapeutics Inc. stock trendline breakdown2025 Key Highlights & Risk Controlled Stock Alerts - Newser
Detecting support and resistance levels for Aldeyra Therapeutics Inc.July 2025 Closing Moves & Short-Term Trading Alerts - Newser
Will Aldeyra Therapeutics Inc. rebound enough to break evenWeekly Stock Recap & Weekly Breakout Watchlists - Newser
Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Aldeyra Therapeutics Inc Azioni (ALDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Machatha Stephen | Chief Development Officer |
Aug 11 '25 |
Sale |
5.15 |
22,073 |
113,713 |
221,799 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):